1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Global Influenza (Flu) Vaccine Market: Trends & Opportunities (2014-19)

Scope of the Report

The report titled “Global Influenza (Flu) Vaccine Market: Trends and Opportunities (2014-2019)” provides an insight into the market dynamics and various trends and opportunities associated with the global Influenza vaccine market. It covers the global market size and growth dynamics of the influenza vaccine market in past five years. The report further forecasts the market size for the coming five years along with factors that could influence the market dynamics in the projected period. The report also captures the market share based on major players in the market. Further, the report also analyzes the domestic Influenza vaccine market of United States, Japan, Germany and United Kingdom. The report concludes with a brief discussion of key factors trending in the global influenza vaccine market and profiles major players like Sanofi, Abbott Laboratories, Novartis, CSL and Glaxo Smith Kline.

Geographical Coverage

Global
United States
Japan
Germany
United Kingdom

Company Coverage

Sanofi
Abbott Laboratories
Novartis
CSL
Glaxo Smith Kline

Executive Summary

With the advancement in technology and discovery of new products in the field of medical sciences, vaccines have gained crucial position in the pharmaceutical industry. Vaccines are considered as the most effective health intervention ever developed, saving innumerable lives. The vaccine market is growing at a steady pace, mainly because of the various existing and emerging diseases which can only be prevented with the help of vaccines. Scientists are continuously engaged in the research and development of effective vaccines to eradicate all major life threatening diseases. There are various organizations namely the Global Alliance for Vaccines and Immunizations (GAVI), World Health Organization (WHO), the World Bank, the United Nations Children's Fund (UNICEF) and Bill and Melinda Gates foundation, which supply vaccines at subsidize rate or even free of cost.

Influenza vaccine constitutes a significant segment of overall vaccine market. The large public attention associated with Influenza A (H1N1, swine flu) pandemic in 2009, growing health awareness in emerging countries has played a significant role in determining the dynamics of the global influenza market.

Table Of Contents

Global Influenza (Flu) Vaccine Market: Trends and Opportunities (2014-19)
1. Executive Summary

2. Global Influenza (Flu) Market: An Introduction

3. Global Vaccine Market: An Analysis

3.1. Global Vaccine Market: Sizing and Growth (Actual and Forecast)
3.2. Global vaccine Market: Segmentation

3.2.1. Human Vaccine Market: Sizing and Growth (Actual and Forecast)
3.2.2. Veterinary Vaccine: Market Sizing and Growth (Actual and Forecast)

4. Global Influenza Market: An Analysis

4.1. Global Influenza Market: Sizing and Growth (Actual and Forecast)
4.2. Global Influenza Vaccine Market: Sizing and Growth (Actual and Forecast)
4.3. Global Influenza Vaccine Market Share Analysis

4.3.1. Market Share: By Capacity
4.3.2. Market Share: By Revenue

4.4. Global Seasonal Flu Vaccine Market Trend

5. Seasonal Influenza Vaccine Market: Regional Analysis

5.1. United States Seasonal Influenza Vaccine Market: Sizing and Growth (Actual and Growth)
5.2. Japan Seasonal Influenza Vaccine Market: Sizing and Growth (Actual and Growth)
5.3. Germany Seasonal Influenza Vaccine Market: Sizing and Growth (Actual and Growth)
5.4. United Kingdom Seasonal Influenza Vaccine Market: Sizing and Growth (Actual and Growth)

6. Global Influenza Vaccine Market Trend

7. Company Profiles

7.1. Sanofi
7.1.1 Business Description
7.1.2. Financial Highlights
7.1.3. Business Strategies

7.2. Abbott Laboratories
7.2.1. Business Description
7.2.2. Financial Highlights
7.2.3. Business Strategies

7.3. Novartis
7.3.1. Business Description
7.3.2. Financial Highlights
7.3.3. Business Strategies

7.4. CSL
7.4.1. Business Description
7.4.2. Financial Highlights
7.4.3. Business Strategies
?
7.5. Glaxo Smith Kline
7.5.1. Business Strategies
7.5.2. Financial Highlights
7.5.3. Business Strategies

Figure 1: Global Vaccine Market Size, 2008-2013, (US$ Billion)
Figure 2: Global Vaccine Market Size Forecast, 2014-2019, (US$ Billion)
Figure 3: Global Human Vaccine Market Size, 2008-2013, (US$ Billion)
Figure 4: Global Human Vaccine Market Size Forecast, 2014-2019, (US$ Billion)
Figure 5: Global Veterinary Vaccine Market Size, 2008-2013, (US$ Billion)
Figure 6: Global Veterinary Vaccine Market Size Forecast, 2014-2019, (US$ Billion)
Figure 7: Global Influenza Market Size, 2008-2013, (US$ Billion)
Figure 8: Global Influenza Market Size Forecast, 2014-2019, (US$ Billion)
Figure 9: Global Influenza Vaccine Market Size, 2008-2013, (US$ Billion)
Figure 10: Global Influenza Vaccine Market Size Forecast, 2014-2019, (US$ Billion)
Figure 11: Global Influenza Vaccine Capacity Market Share, By Major Players, 2012
Figure 12: Global Influenza Vaccine Market Share, By Major Players
Figure 13: Global Seasonal Flu Vaccine Market Size, By Region, 2008-2013 (US$ Million)
Figure 14: United States Seasonal Influenza Vaccine Market Size, 2008-2013, (US$ Million)
Figure 15: United States Seasonal Influenza Vaccine Market Size Forecast, 2014-2019, (US$ Million)
Figure 16: Japan Seasonal Influenza Vaccine Market Size, 2008-2013, (US$ Million)
Figure 17: Japan Seasonal Influenza Vaccine Market Size Forecast, 2014-2019, (US$ Million)
Figure 18: Germany Seasonal Influenza Vaccine Market Size, 2008-2013, (US$ Million)
Figure 19: Germany Seasonal Influenza Vaccine Market Size Forecast, 2014-2019, (US$ Million)
Figure 20: United Kingdom Seasonal Influenza Vaccine Market Size, 2008-2013, (US$ Million)
Figure 21: United Kingdom Seasonal Influenza Vaccine Market Size Forecast, 2014-2019, (US$ Million)
Figure 22: Sanofi Vaccine Net Sales, 2009-2013 (US$ Million)
Figure 23: Abbott Net Sales, 2011-2013 (US$ Billion)
Figure 24: Novartis Vaccine and Diagnostics Net Sales, 2009-2013 (US$ Million)
Figure 25: Novartis Net Sales, By Sector (FY' 2013)
Figure 26: CSL Global Revenue, FY'2009-FY'2013 (US$ Million)
Figure 27: CSL Limited Net Sales, By Sector (First Half FY' 2014)
Figure 28: GSK Flaurix/Flulaval Turnover, 2010-2013 (US$ Million)
Figure 29: GSK Global Turnover, By Segment, 2013
Figure 30: GSK Global Turnover, By Region, 2013
Table 1: Number of Doses sold by Novartis, 2013, (Million)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...

Veterinary Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Veterinary Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

Veterinary vaccines are extensively used in the prevention of life-threatening animal diseases. This report on the global veterinary vaccines market analyzes the current and future prospects of the market. ...

Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Human Vaccines Market: Scope and Methodology This report provides in-depth region wise and country wise analysis of the human vaccines market. Stakeholders of this report include manufacturers of human ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.